NBIS Q1 2026 Earnings Significant EPS Beat Despite Revenue Absence KOP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency SOHON Q2 2025 Earnings Preferred EPS of 021 Reported Stock Edges Lower Z Q1 2026 Earnings EPS Surges Past Estimates Amid Market Optimism Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones TUSK Q1 2026 Earnings Return to Profitability Drives Shares Higher